Rebaseline no evidence of disease activity (neda-3) as a predictor of long-term disease course in a norwegian multiple sclerosis population

HIGHLIGHTS

• who: Cecilia Smith Simonsen from the Careggi University Hospital, Italy have published the Article: Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population, in the Journal: Neurology, Hospital Telemark HF, Skien, Norway, 3 Institute of Clinical Medicine, University of Oslo,
• what: For one, the clinical measures are crude and the concept is overly reliant on MRI findings, with the main focus on focal inflammatory disease activity, thus underestimating silent neurodegeneration and chronic lesions .
• how: The Regional Ethics Committee in Norway . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.